Jianxin Pang

1.8k total citations
87 papers, 1.4k citations indexed

About

Jianxin Pang is a scholar working on Molecular Biology, Nephrology and Surgery. According to data from OpenAlex, Jianxin Pang has authored 87 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 29 papers in Nephrology and 18 papers in Surgery. Recurrent topics in Jianxin Pang's work include Gout, Hyperuricemia, Uric Acid (29 papers), Case Reports on Hematomas (12 papers) and Pharmacological Effects of Natural Compounds (6 papers). Jianxin Pang is often cited by papers focused on Gout, Hyperuricemia, Uric Acid (29 papers), Case Reports on Hematomas (12 papers) and Pharmacological Effects of Natural Compounds (6 papers). Jianxin Pang collaborates with scholars based in China, Hong Kong and United States. Jianxin Pang's co-authors include Ting Wu, Zean Zhao, Pingzheng Zhou, Ying Cao, Shaoyu Wu, Weiming Fu, Yuanxin Tian, Jiajie Zhang, Feng Lu and Jian Luo and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Journal of Agricultural and Food Chemistry.

In The Last Decade

Jianxin Pang

81 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jianxin Pang China 23 630 459 240 174 149 87 1.4k
Katarzyna Wójcik‐Pszczoła Poland 20 503 0.8× 213 0.5× 139 0.6× 98 0.6× 92 0.6× 71 1.5k
Yang Lv China 24 651 1.0× 178 0.4× 121 0.5× 109 0.6× 132 0.9× 77 1.3k
Haiyang Yu China 23 867 1.4× 129 0.3× 225 0.9× 116 0.7× 327 2.2× 92 1.9k
Juan Jin China 22 759 1.2× 278 0.6× 76 0.3× 100 0.6× 272 1.8× 50 1.3k
Mohamed S. Abdel‐Bakky Egypt 20 670 1.1× 146 0.3× 100 0.4× 118 0.7× 226 1.5× 67 1.5k
Zhigang Zhang China 17 717 1.1× 448 1.0× 48 0.2× 129 0.7× 135 0.9× 64 1.5k
Jiancheng Guo China 20 571 0.9× 408 0.9× 59 0.2× 129 0.7× 91 0.6× 41 1.9k
Lingling Wu China 21 468 0.7× 260 0.6× 54 0.2× 106 0.6× 101 0.7× 65 1.2k
Yongheng Bai China 26 990 1.6× 167 0.4× 100 0.4× 205 1.2× 254 1.7× 74 1.9k
Xinyan Chen China 16 412 0.7× 203 0.4× 54 0.2× 110 0.6× 83 0.6× 81 999

Countries citing papers authored by Jianxin Pang

Since Specialization
Citations

This map shows the geographic impact of Jianxin Pang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianxin Pang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianxin Pang more than expected).

Fields of papers citing papers by Jianxin Pang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianxin Pang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianxin Pang. The network helps show where Jianxin Pang may publish in the future.

Co-authorship network of co-authors of Jianxin Pang

This figure shows the co-authorship network connecting the top 25 collaborators of Jianxin Pang. A scholar is included among the top collaborators of Jianxin Pang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianxin Pang. Jianxin Pang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Chunxia, Wenxin Wang, Haoyang Chen, et al.. (2025). Structure optimization of natural product piperine to obtain novel and potent analogs with anti-inflammation pain and urate-lowering effect. European Journal of Medicinal Chemistry. 292. 117649–117649.
2.
3.
Zeng, Chao, et al.. (2024). Antidepressant effect of carvedilol on streptozotocin-induced diabetic peripheral neuropathy mice by altering gut microbiota. Biochemical and Biophysical Research Communications. 730. 150374–150374. 2 indexed citations
4.
Zhao, Zean, Xinhua Chen, Jiajun Luo, et al.. (2024). Design, synthesis and bioactivity evaluation of isobavachin derivatives as hURAT1 inhibitors for hyperuricemia agents. European Journal of Medicinal Chemistry. 277. 116753–116753. 3 indexed citations
5.
6.
Wu, Yu‐Chiao, et al.. (2024). Predicting Vulnerability Status of Carotid Plaques Using CTA-Based Quantitative Analysis. Journal of Cardiovascular Pharmacology. 85(3). 217–224. 3 indexed citations
7.
Wu, Xiaoyan, Xin Yi, Boxin Zhao, et al.. (2023). The volume regulated anion channel VRAC regulates NLRP3 inflammasome by modulating itaconate efflux and mitochondria function. Pharmacological Research. 198. 107016–107016. 21 indexed citations
8.
Luo, Jiajun, Xinhua Chen, Zean Zhao, et al.. (2023). Mechanism of anti-hyperuricemia of isobavachin based on network pharmacology and molecular docking. Computers in Biology and Medicine. 155. 106637–106637. 16 indexed citations
9.
Wen, Kangmei, et al.. (2023). Copper-Mediated C4-Benzylations of 5-Aminopyrazoles with 3-Indoleacetic Acids. The Journal of Organic Chemistry. 88(11). 6623–6632. 11 indexed citations
10.
Zhao, Zean, Hui Liao, Yongjun Chen, et al.. (2022). Mutation in Transmembrane Domain 8 of Human Urate Transporter 1 Disrupts Uric Acid Recognition and Transport. ACS Omega. 7(38). 34621–34631. 7 indexed citations
11.
Zhang, Jian, Yue Dong, Shenghua Gao, et al.. (2022). Design, synthesis and activity evaluation of novel lesinurad analogues containing thienopyrimidinone or pyridine substructure as human urate transporter 1 inhibitors. European Journal of Medicinal Chemistry. 244. 114816–114816. 8 indexed citations
12.
Li, Lu, Kangmei Wen, Jie Deng, et al.. (2021). Copper-Catalyzed C-3 Functionalization of Imidazo[1,2-a]pyridines with 3-Indoleacetic Acids. The Journal of Organic Chemistry. 86(17). 12394–12402. 26 indexed citations
13.
Zhao, Tong, Qing Meng, Yanyu Chen, et al.. (2020). Novel Human Urate Transporter 1 Inhibitors as Hypouricemic Drug Candidates with Favorable Druggability. Journal of Medicinal Chemistry. 63(19). 10829–10854. 41 indexed citations
14.
Li, Lü, Kangmei Wen, Xingang Yao, et al.. (2020). Copper-Mediated Decarboxylative Sulfonylation of Arylacetic Acids with Sodium Sulfinates. Organic Letters. 22(18). 7164–7168. 27 indexed citations
15.
Zhao, Zean, Jiang Yu, Lu Li, et al.. (2020). Structural Insights into the Atomistic Mechanisms of Uric Acid Recognition and Translocation of Human Urate Anion Transporter 1. ACS Omega. 5(51). 33421–33432. 25 indexed citations
16.
Zhao, Tingting, Zean Zhao, Shan Chang, et al.. (2019). Two- and three-dimensional QSAR studies on hURAT1 inhibitors with flexible linkers: topomer CoMFA and HQSAR. Molecular Diversity. 24(1). 141–154. 12 indexed citations
17.
Li, Haixin, Ying Huang, Xian Wu, et al.. (2018). Effects of hemocoagulase agkistrodon on the coagulation factors and its procoagulant activities. Drug Design Development and Therapy. Volume 12. 1385–1398. 14 indexed citations
18.
Qin, Liang, Ziyan Sun, Kai Cheng, et al.. (2017). Zwitterionic Manganese and Gadolinium Metal–Organic Frameworks as Efficient Contrast Agents for in Vivo Magnetic Resonance Imaging. ACS Applied Materials & Interfaces. 9(47). 41378–41386. 62 indexed citations
19.
Wang, Guangfa, Junyan Zhang, Shaoyu Wu, et al.. (2010). Praeruptorin a inhibits lipopolysaccharide‐induced inflammatory response in murine macrophages through inhibition of NF‐κB pathway activation. Phytotherapy Research. 25(4). 550–556. 33 indexed citations
20.
Lv, Lin, Shaoyu Wu, Shaoyu Wu, et al.. (2009). Effect of astragaloside IV on hepatic glucose‐regulating enzymes in diabetic mice induced by a high‐fat diet and streptozotocin. Phytotherapy Research. 24(2). 219–224. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katarzyna Wójcik‐Pszczoła Breakdown of academic impact, for papers by Yang Lv Breakdown of academic impact, for papers by Haiyang Yu Breakdown of academic impact, for papers by Juan Jin Breakdown of academic impact, for papers by Mohamed S. Abdel‐Bakky Breakdown of academic impact, for papers by Zhigang Zhang Breakdown of academic impact, for papers by Jiancheng Guo Breakdown of academic impact, for papers by Lingling Wu Breakdown of academic impact, for papers by Yongheng Bai Breakdown of academic impact, for papers by Xinyan Chen
Rankless by CCL
2026